We are honored and thrilled to announce that Stephen A. Back, M.D., Ph.D., will be the Scientific Keynote Speaker at the Hydrocephalus Association’s 13th National Conference on Hydrocephalus: Community. Clarity. Cure.
Dr. Back is a Professor of Pediatrics and Neurology, Oregon Health & Science University, Clyde and Elda Munson Professor of Pediatric Research, Director, Neuroscience Section, Pape’ Family Pediatric Research Institute. Dr. Back will address his important work on the development of strategies to promote regeneration and repair of injury to the developing brain.
“Dr. Back is a true national and international expert on mechanisms of damage to the brain of premature infants who suffer from periventricular leukomalacia and hydrocephalus. His research is leading us rapidly towards cures that will dramatically improve the lives of these children,” stated Dr. Nathan Selden, Conference Medical Chair.
Dr. Stephen A. Back received his Ph.D. in Pharmacology in 1989 and his M.D. in 1990 from the University of California, Irvine. His Ph.D. studies defined CNS roles for enkephalin-degrading enzymes in the opiate system. He is Professor of Pediatrics, Neurology and Anesthesiology at Oregon Health & Science University-Doernbecher Children’s Hospital. He is Director of the Division of Pediatric Neuroscience and holds the Clyde and Elda Munson Professorship in Pediatric Research.
Dr. Back completed residency training in Pediatrics at UC Irvine and in Pediatric Neurology at Boston Children’s Hospital–Harvard Medical School. At Harvard, he completed a research fellowship in the laboratory of Dr. Joseph Volpe and a clinical fellowship in cerebral palsy supported by the United Cerebral Palsy Foundation. In Dr. Volpe’s lab, Dr. Back defined maturation-dependent mechanisms of vulnerability of the oligodendrocyte lineage to oxidative stress and defined oligodendrocyte lineage maturation during human white matter development. Dr. Back has published more than 75 original articles. He is the recipient of a Young Investigator Award from the Child Neurology Society, a Bugher Award from the American Heart Association and a NINDS-Javits Merit Award from the National Institutes of Health. His research has been supported by grants from NINDS, NIA, the March of Dimes and the American Heart Association.
The current research interests of Dr. Back’s lab include: cellular, molecular and high field MRI studies to define chronic cerebral gray and white matter lesions arising from hypoxia-ischemia in human, rodents and fetal sheep; anesthesia toxicity to non-human primate CNS white matter; role of the extracellular matrix in myelination failure in neonatal, multiple sclerosis and vascular dementia related white matter lesions; and pathogenesis of cerebral white matter injury related to vascular cognitive impairment in the aging human brain. The long-term objective of the studies in Dr. Back’s lab is to develop successful interventions to promote regeneration and repair of brain injury arising from complications of prematurity.
A main goal of the Hydrocephalus Association is improving the quality of life for people living with hydrocephalus through support and education, research and advocacy. We lead and empower our community to advocate for more federal support of hydrocephalus research and encourage interest and collaboration in the private research community. We also work closely with other national organizations with similar goals to improve health policy for all people, especially those with chronic medical conditions like hydrocephalus. Join us Portland, OR July 9-11th this year and support our efforts.